Vitiligo - 11/04/24
Doi : 10.1016/j.jaad.2023.12.040
Rohan Manoj, MBBS, Shrishti Singh, MBBS, Rohit Kothari, MBBS, MD, Aayush Gupta, MBBS, MD ⁎ 
Department of Dermatology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India
∗Correspondence to: Aayush Gupta, MBBS, MD, Department of Dermatology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.Department of DermatologyDr. D.Y. Patil Medical CollegeHospital and Research CentreDr. D.Y. Patil VidyapeethPimpri, PuneMaharashtraIndia
Key words : general dermatology, skin of color, vitiligo
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
© 2024
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 90 - N° 5
P. 1106-1114 - maggio 2024 Ritorno al numero
Articolo precedente
- Dermatology images: Lupus erythematosus
- Dirk M. Elston
- JAAD Game Changer: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients
- Wendi E. Wohltmann
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?